on AFYREN (EPA:ALAFY)
AFYREN NEOXY Achieves First Significant Revenue in 2025
On January 15, 2026, AFYREN announced that its joint venture, AFYREN NEOXY, generated its first significant revenue in 2025, a milestone for the company's bio-based production. This comes after producing around 400 tons of bio-based acids and associated fertilizers, resulting in sales of approximately €1 million, with €0.5 million invoiced by the year's end.
The year 2025 was marked by AFYREN's shift to continuous production, despite temporary pauses mid-year to tackle operational bottlenecks. Production surged in the last two months, contributing heavily to the annual output. The company anticipates further growth in 2026.
AFYREN NEOXY successfully supplied products to nine clients, underpinned by existing contracts and the acquisition of new customers across diverse sectors, including Flavors and Fragrances and Life Sciences. All production volumes have secured sales outlets, indicating strong market confidence.
R. P.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all AFYREN news